Engineers Gate Manager LP Sellas Life Sciences Group, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.88 - $1.57 $14,834 - $26,465	16,857 New	16,857 $17,000
Q3 2021 Nov 15, 2021	SELL	$8.21 - $10.53 $228,492 - $293,060	-27,831 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.19 - $13.71 $12,079 - $23,032	1,680 Added 6.42%	27,831 $309,000
Q1 2021 May 17, 2021	BUY	$5.5 - $11.71 $63,530 - $135,262	11,551 Added 79.12%	26,151 $223,000
Q4 2020 Feb 16, 2021	BUY	$2.45 - $17.66 $35,770 - $257,836	14,600 New	14,600 $85,000

7.08M

1.8M

49.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $26.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.